Bethan Psaila

9.8k total citations · 3 hit papers
61 papers, 5.5k citations indexed

About

Bethan Psaila is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Bethan Psaila has authored 61 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 29 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Bethan Psaila's work include Platelet Disorders and Treatments (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers) and Blood groups and transfusion (14 papers). Bethan Psaila is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers) and Blood groups and transfusion (14 papers). Bethan Psaila collaborates with scholars based in United Kingdom, United States and Australia. Bethan Psaila's co-authors include David Lyden, Rosandra N. Kaplan, James B. Bussel, J.M. Jenkins, Drew Provan, Bruno Costa‐Silva, Gonçalo Rodrigues, Ayuko Hoshino, Irina Matei and Héctor Peinado and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Bethan Psaila

54 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pre-metastatic niches: organ-specific homes for metastases

2017 1.4k citations Héctor Peinado, Haiying Zhang et al. Nature reviews. Cancer profile →
The metastatic niche: adapting the foreign soil

2009 980 citations Bethan Psaila, David Lyden Nature reviews. Cancer profile →
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

2007 565 citations James B. Bussel, Gregory Cheng et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bethan Psaila	2.1k	1.9k	1.5k	1.1k	890	61	5.5k
Lia Gore	1.1k 0.5×	2.6k 1.4×	2.6k 1.7×	632 0.6×	743 0.8×	202	6.1k
Giannoula Klement	847 0.4×	2.3k 1.3×	1.7k 1.1×	1.2k 1.1×	477 0.5×	67	4.9k
Benjamin Esterni	1.0k 0.5×	1.4k 0.8×	2.2k 1.4×	1.0k 0.9×	380 0.4×	75	4.4k
Marek Z. Wojtukiewicz	996 0.5×	1.0k 0.6×	2.2k 1.4×	939 0.8×	592 0.7×	190	4.5k
Nashat Gabrail	828 0.4×	1.6k 0.9×	2.3k 1.5×	1.1k 0.9×	251 0.3×	154	4.4k
Roy B. Jones	3.4k 1.6×	970 0.5×	2.5k 1.6×	770 0.7×	791 0.9×	176	6.6k
Pier Francesco Ferrucci	1.2k 0.6×	2.9k 1.6×	3.7k 2.4×	409 0.4×	1.7k 1.9×	141	6.2k
Natalie S. Callander	4.0k 1.9×	3.2k 1.7×	2.8k 1.8×	478 0.4×	573 0.6×	199	5.9k
Robert B. Gerbing	3.9k 1.8×	4.6k 2.4×	2.1k 1.4×	2.1k 1.9×	672 0.8×	239	11.0k
Maurizio Martini	536 0.3×	2.3k 1.3×	1.9k 1.3×	1.3k 1.1×	614 0.7×	281	6.5k

Countries citing papers authored by Bethan Psaila

Since Specialization

Citations

This map shows the geographic impact of Bethan Psaila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bethan Psaila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bethan Psaila more than expected).

Fields of papers citing papers by Bethan Psaila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bethan Psaila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bethan Psaila. The network helps show where Bethan Psaila may publish in the future.

Co-authorship network of co-authors of Bethan Psaila

This figure shows the co-authorship network connecting the top 25 collaborators of Bethan Psaila. A scholar is included among the top collaborators of Bethan Psaila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bethan Psaila. Bethan Psaila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Zoë C. & Bethan Psaila. (2025). The Road Less Traveled: T Cell-Engaging Immunotherapies for Myeloid Malignancies. The Hematologist. 22(1).

Mead, Adam J., Brian J.P. Huntly, Bethan Psaila, et al.. (2024). Interim Analysis of Promise, a Clinical Study Combining the BET Inhibitor OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis Experiencing an Inadequate Response to Ruxolitinib. Blood. 144(Supplement 1). 3186–3186.

Wang, Guanlin, Wei Wen, Adam J. Mead, et al.. (2022). Processing single-cell RNA-seq datasets using SingCellaR. STAR Protocols. 3(2). 101266–101266. 2 indexed citations

Sousos, Nikolaos, Máire Ní Leathlobhair, Christina Simoglou Karali, et al.. (2022). In utero origin of myelofibrosis presenting in adult monozygotic twins. Nature Medicine. 28(6). 1207–1211. 33 indexed citations

Mughal, Tariq I., Bethan Psaila, Daniel J. DeAngelo, et al.. (2021). Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021. Haematologica. 106(7). 1787–1793. 4 indexed citations

Roy, Anindita, Guanlin Wang, Deena Iskander, et al.. (2021). Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development. Cell Reports. 36(11). 109698–109698. 34 indexed citations

Peng, Hua, Joanna Hester, Rong Li, et al.. (2020). The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes. Blood. 136(21). 2410–2415. 20 indexed citations

Mughal, Tariq I., Naveen Pemmaraju, Bethan Psaila, et al.. (2020). Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies. Hematological Oncology. 38(5). 654–664. 1 indexed citations

Rodríguez-Meira, Alba, Gemma Buck, Sally‐Ann Clark, et al.. (2019). Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing. Molecular Cell. 73(6). 1292–1305.e8. 204 indexed citations

10.

Peinado, Héctor, Haiying Zhang, Irina Matei, et al.. (2017). Pre-metastatic niches: organ-specific homes for metastases. Nature reviews. Cancer. 17(5). 302–317. 1350 indexed citations breakdown →

11.

Psaila, Bethan, Nikolaos Barkas, Deena Iskander, et al.. (2016). Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways. Genome biology. 17(1). 83–83. 98 indexed citations

12.

Psaila, Bethan, David Lyden, & Ian Roberts. (2011). Megakaryocytes, malignancy and bone marrow vascular niches. Journal of Thrombosis and Haemostasis. 10(2). 177–188. 55 indexed citations

13.

Psaila, Bethan, J B Bussel, Sandra Y. Vasey, et al.. (2008). EFFICACY AND SAFETY OF REPEATED INTERMITTENT TREATMENT WITH ELTROMBOPAG IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP). 93. 120–120. 2 indexed citations

14.

Psaila, Bethan & James B. Bussel. (2008). Refractory immune thrombocytopenic purpura: current strategies for investigation and management. British Journal of Haematology. 143(1). 16–26. 64 indexed citations

15.

Bussel, J B, Guang‐Shing Cheng, Mohammad Saleh, et al.. (2007). Eltrombopag, an oral platelet growth factor, for treatment of chronic immune thrombocytopenic purpura (ITP): A randomized, double-blind, placebo-controlled trial. 5. 66–67. 1 indexed citations

16.

Kaplan, Rosandra N., Bethan Psaila, & David Lyden. (2007). Niche-to-niche migration of bone-marrow-derived cells. Trends in Molecular Medicine. 13(2). 72–81. 153 indexed citations

17.

Psaila, Bethan & James B. Bussel. (2007). Immune Thrombocytopenic Purpura. Hematology/Oncology Clinics of North America. 21(4). 743–759. 65 indexed citations

18.

Psaila, Bethan, Drew Provan, John M. Hamilton, et al.. (2007). The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. British Journal of Haematology. 138(2). 245–248. 124 indexed citations

19.

Bussel, James B., Gregory Cheng, Mansoor N. Saleh, et al.. (2007). Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 357(22). 2237–2247. 565 indexed citations breakdown →

20.

Kaplan, Rosandra N., Bethan Psaila, & David Lyden. (2006). Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer and Metastasis Reviews. 25(4). 521–529. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact